This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fuelling Growth: Strategic Investments, Acquisitions, and Expansions Samsung Biologics unveiled plans to expand capacity and geographic reach by initiating the construction of Bio Campus II with a $6 billion investment scheduled to begin operations in 2025 while completing its CGMP antibody-drug conjugate manufacturing facility within 2024.
Updated: February 2025 Biopharmaceutical consultants and consulting firms play a pivotal role in guiding companies through the intricate landscape of drug development, regulatory compliance, and market strategies. The Value of a Biopharma Consulting Firm Beyond mere compliance, these consultants offer strategic vision.
Updated: February 2025 "Science and everyday life cannot and should not be separated." - Rosalind Franklin It should go without saying, but life science can be quite complicated. Why work with Eradigm Consulting: Eradigm Consulting's approach is driven by a passion for high performance and delivering excellence in the biopharma industry.
Held in New York during March 17-20, 2025, the event focused on pharmaceutical innovation, industry outlook, capacity expansion, and supply chain resilience, driven by the increasing digitization of drug development and manufacturing. trillion in 2024, is expected to grow at a 7% CAGR through 2030.
Download our full analysis on the top 10 strategic imperatives shaping life sciences in 2025. Growth Opportunities: Cloud-Native Multi-Lab Collaboration: SaaS facilitates seamless data sharing across multiple labs, improving diagnostic accuracy and operational efficiency. Want deeper insights? Want deeper insights?
Updated: February 2025 In the intricate world of biotechnology, snagging the perfect talent feels like searching for a rare gene in a vast genome. They not only understand the technical qualifications required for a role but also appreciate the importance of soft skills and cultural fit in such a collaborative and fast-paced industry.
The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors. Key Examples : Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, Inc.
We organize all of the trending information in your field so you don't have to. Join 61,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content